NCLEX-PN

Evaluating Client Responses to Treatment for Infectious Diseases Assessing the client's response to treatment for infectious diseases is a critical aspect of healthcare management. Below is an overview of the evaluation process for client responses to treatment, focusing on HIV/AIDS and tuberculosis (TB) as examples of infectious diseases. HIV/AIDS Evaluation ●​ Data Collection: Continuously gather data on the client's condition, including signs and symptoms of infection, laboratory results (e.g., CD4 T-cell counts, viral load), and any associated complications. ●​ Assessment of Opportunistic Infections: Monitor for opportunistic infections, such as Kaposi's sarcoma, herpes simplex, and Pneumocystis jirovecii pneumonia, and other HIV-related disorders. Assess the severity and progression of these infections. ●​ Assessment of Signs and Symptoms: Evaluate the presence and severity of common HIV/AIDS-related signs and symptoms, including headaches, lymphadenopathy, diarrhea, weight loss, and skin rash. ●​ Assessment of Medication Response: Monitor the client's response to highly active combination antiretroviral therapy (HAART). Assess changes in viral load and CD4 T-cell counts to gauge treatment effectiveness. ●​ Assessment of Adverse Effects: Evaluate for adverse effects or complications associated with antiretroviral medications, such as peripheral neuropathy, acid-base imbalances, and electrolyte disorders. ●​ Monitoring Physical Status: Continually assess the client's overall physical status, including vital signs, weight, and general well-being. TB Evaluation: ●​ Symptom Assessment: Monitor the client for symptoms of TB, including fever, night sweats, productive cough (sometimes with blood), chest pain, and fatigue. ●​ Drug Resistance: Be vigilant for signs of drug-resistant TB, which is a serious complication. Assess whether treatment is effective and if drug resistance is emerging. ●​ Medication Response: Evaluate the response to TB medications, which often involve combination therapy. Assess adherence to treatment regimens and any adverse effects experienced by the client. ●​ Radiological Evaluation: Consider radiological tests, such as chest X-rays, to assess the extent of lung involvement and any changes in the appearance of lung lesions. ●​ Sputum Culture and Smear: Monitor the results of sputum cultures and smears to determine the presence of Mycobacterium tuberculosis and assess treatment progress.

536

© 2025 ACHIEVE ULTIMATE CREDIT-BY-EXAM GUIDE | NCLEX-PN ​

​

​

​

​